Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson's disease.

Parkinson’s acetylcholine basal forebrain cognition free water

Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
18 Dec 2023
Historique:
received: 08 08 2023
revised: 12 11 2023
accepted: 02 12 2023
medline: 18 12 2023
pubmed: 18 12 2023
entrez: 18 12 2023
Statut: aheadofprint

Résumé

Most individuals with Parkinson's disease experience cognitive decline. Mounting evidence suggests this is partially caused by cholinergic denervation due to α-synuclein pathology in the cholinergic basal forebrain. Alpha-synuclein deposition causes inflammation, which can be measured with free water fraction, a diffusion MRI-derived metric of extracellular water. Prior studies have shown an association between basal forebrain integrity and cognition, cholinergic levels and cognition, and basal forebrain volume and acetylcholine, but no study has directly investigated whether basal forebrain physiology mediates the relationship between acetylcholine and cognition in Parkinson's disease. We investigated the relationship between these variables in a cross-sectional analysis of 101 individuals with Parkinson's disease. Cholinergic levels were measured using Fluorine-18 fluoroethoxybenzovesamicol PET imaging. Cholinergic innervation regions of interest included the medial, lateral capsular, and lateral perisylvian regions and the hippocampus. Brain volume and free water fraction were quantified using T1 and diffusion MRI, respectively. Cognitive measures included composites of attention/working memory, executive function, immediate memory, and delayed memory. Data were entered into parallel mediation analyses with the cholinergic projection areas as predictors, cholinergic basal forebrain volume and free water fraction as mediators, and each cognitive domain as outcomes. All mediation analyses controlled for age, years of education, levodopa equivalency dose, and systolic blood pressure. The basal forebrain integrity metrics fully mediated the relationship between lateral capsular and lateral perisylvian acetylcholine and attention/working memory, and partially mediated the relationship between medial acetylcholine and attention/working memory. Basal forebrain integrity metrics fully mediated the relationship between medial, lateral capsular, and lateral perisylvian acetylcholine and free water fraction. For all mediations in attention/working memory and executive function the free water mediation was significant, while the volume mediation was not. The basal forebrain integrity metrics fully mediated the relationship between hippocampal acetylcholine and delayed memory and partially mediated the relationship between lateral capsular and lateral perisylvian acetylcholine and delayed memory. The volume mediation was significant for the hippocampal and lateral perisylvian models, while free water fraction was not. Free water fraction in the cholinergic basal forebrain mediates the relationship between acetylcholine and attention/working memory and executive function, while cholinergic basal forebrain volume mediated the relationship between acetylcholine in temporal regions in memory. These findings suggest that these two metrics reflect different stages of neurodegenerative processes, and add additional evidence for a relationship between pathology in the basal forebrain, acetylcholine denervation, and cognitive decline in Parkinson's disease.

Identifiants

pubmed: 38109781
pii: 7477817
doi: 10.1093/brain/awad420
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.

Auteurs

Samual J Crowley (SJ)

Research Program on Cognition and Neuromodulation Based Interventions, Department of Psychiatry, University of Michigan, Ann Arbor, MI 48105, USA.
Mental Health Service, Veterans Administration Ann Arbor Healthcare System, Ann Arbor, MI 48105, USA.

Prabesh Kanel (P)

Department of Radiology, University of Michigan, Ann Arbor, MI 48105, USA.
Morris K. Udall Center of Excellence for Parkinson's Disease Research, University of Michigan, Ann Arbor, MI 48105, USA.
Parkinson's Foundation Center of Excellence, University of Michigan, Ann Arbor, MI, USA.

Stiven Roytman (S)

Department of Radiology, University of Michigan, Ann Arbor, MI 48105, USA.

Nicolaas I Bohnen (NI)

Department of Radiology, University of Michigan, Ann Arbor, MI 48105, USA.
Morris K. Udall Center of Excellence for Parkinson's Disease Research, University of Michigan, Ann Arbor, MI 48105, USA.
Parkinson's Foundation Center of Excellence, University of Michigan, Ann Arbor, MI, USA.
Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
Neurology Service and GRECC, Veterans Administration Ann Arbor Healthcare System, Ann Arbor, MI 48105, USA.

Benjamin M Hampstead (BM)

Research Program on Cognition and Neuromodulation Based Interventions, Department of Psychiatry, University of Michigan, Ann Arbor, MI 48105, USA.
Mental Health Service, Veterans Administration Ann Arbor Healthcare System, Ann Arbor, MI 48105, USA.

Classifications MeSH